相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pheochromocytoma and Paraganglioma in Cyanotic Congenital Heart Disease
Alexander R. Opotowsky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PHEOCHROMOCYTOMA AND TETRALOGY OF FALLOT: A RARE BUT POTENTIALLY DANGEROUS COMBINATION
Rajeev Kasaliwal et al.
ENDOCRINE PRACTICE (2014)
Succinate-to-Fumarate Ratio as a New Metabolic Marker to Detect the Presence of SDHB/D-related Paraganglioma: Initial Experimental and Ex Vivo Findings
Nikoletta Lendvai et al.
ENDOCRINOLOGY (2014)
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
Esra A. Akbay et al.
GENES & DEVELOPMENT (2014)
Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X
Nan Qin et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency
Susan Richter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction inNeuroblastoma
Christopher J. Mariani et al.
CELL REPORTS (2014)
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
Mechanical properties of DNA-like polymers
Justin P. Peters et al.
NUCLEIC ACIDS RESEARCH (2013)
High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma
Irina Bancos et al.
PLOS ONE (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor
J. Keith Killian et al.
CANCER DISCOVERY (2013)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression
Robin M. Ricke et al.
JOURNAL OF CELL BIOLOGY (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
SDH mutations in cancer
Chiara Bardella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
Mei Yee Koh et al.
CANCER RESEARCH (2011)
Metastatic Pheochromocytoma/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link to SDHB Mutations
Kathryn S. King et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pheochromocytomas: The (pseudo)-hypoxia hypothesis
Judith Favier et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma
Nidia Y. Cerecer-Gil et al.
CLINICAL CANCER RESEARCH (2010)
SDHA is a tumor suppressor gene causing paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2010)
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes
Anthony J. Gill et al.
HUMAN PATHOLOGY (2010)
A Catecholamine Crisis on Mount Kilimanjaro: A Hypoxia Effect?
Montserrat Ayala-Ramirez et al.
JOURNAL OF TRAVEL MEDICINE (2010)
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David L. DiGiusto et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
siRNA vs. shRNA: Similarities and differences
Donald D. Rao et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Pheochromocytomas: From Genetic Diversity to New Paradigms
Y. Qin et al.
HORMONE AND METABOLIC RESEARCH (2009)
Determination of 5-methyl-2′-deoxycytidine in genomic DNA using high performance liquid chromatography-ultraviolet detection
Jatinderpal Sandhu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
Francien H. van Nederveen et al.
LANCET ONCOLOGY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Intensive RNAi with lentiviral vectors in mammalian cells
Tanner Miest et al.
METHODS (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
D. A. Tennant et al.
ONCOGENE (2009)
The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
Judith Favier et al.
PLOS ONE (2009)
SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Huai-Xiang Hao et al.
SCIENCE (2009)
Loss of the SdhB, but not the SdhA subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis
Robert D. Guzy et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Emily H. Smith et al.
HUMAN MOLECULAR GENETICS (2007)
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas
Laurence Amar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells
Elaine D. MacKenzie et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates -: Possible links between cell metabolism and stabilization of HIF
Peppi Koivunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Expression of HIF-1α, HIF-2α (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations
Patrick J. Pollard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Microbial metabolomics with gas chromatography/mass spectrometry
MM Koek et al.
ANALYTICAL CHEMISTRY (2006)
Mitochondrial succinate is instrumental for HIF1α nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions
JJ Brière et al.
HUMAN MOLECULAR GENETICS (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
A HIF1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas
PLM Dahia et al.
PLOS GENETICS (2005)
Retinal degeneration and local oxygen metabolism
DY Yu et al.
EXPERIMENTAL EYE RESEARCH (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress
K Salnikow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice
DJ Baker et al.
NATURE GENETICS (2004)
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
M Hirsilä et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect
K Astrom et al.
HUMAN GENETICS (2003)
Two cases of pheochromocytoma associated with tetralogy of Fallot
T Kita et al.
HYPERTENSION RESEARCH (2003)
Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma
AP Gimenez-Roqueplo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas
BE Baysal et al.
JOURNAL OF MEDICAL GENETICS (2002)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway
AP Gimenez-Roqueplo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
D Astuti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
S Niemann et al.
NATURE GENETICS (2000)
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
BE Baysal et al.
SCIENCE (2000)
分享论文
